Melinta Therapeutics (United States)

Melinta Therapeutics is a pharmaceutical company focused on antibiotics for serious bacterial infections. The company markets Baxdela (delafloxacin) for skin infections and pneumonia, Vabomere and Orbactiv for resistant infections, and Kimyrsa for MRSA bloodstream infections. Melinta addresses the critical need for new antibiotics against multidrug-resistant bacteria.